Table 1.

Summary of NIH treatment guidelines for CoVID-19

Disease severity	Recommended drugs
Not requiring hospitalization	Bamlanivimab plus etesevimab or Casirivimab plus imdevimab or Sotrovimab Do not use dexamethasone or other corticosteroids
Discharged from hospital in stable conditions and not requiring supplemental oxygen	Do not use dexamethasone, remdesivir, or baricitinib
Discharged from hospital and requiring supplemental oxygen	Insufficient evidence to recommend or not continuing the in-hospital therapy with remdesivir, dexamethasone, and/or baricitinib
Discharged from hospital and increasing need for supplemental oxygen	Dexamethasone for the duration of supplemental oxygen
Hospitalized and not requiring supplemental oxygen	Insufficient evidence to recommend or not remdesivir Do not use dexamethasone or other corticosteroids
Hospitalized and requiring supplemental oxygen	Remdsivir or Dexamethasone Or Dexamethasone + remdsivir
Hospitalized and requiring supplemental oxygen through a high-flow device or non-invasive ventilation	Dexamethasone or Dexamethasone + remdsivir
Hospitalized and requiring mechanical ventilation or extracorporeal membrane oxygenation	Dexamethasone Dexamethasone + tocilizumab (or sarilumab, if tocilizumab unavailable) for patients who are within 24 h of admission to intensive care unit